Aehr Test Systems, Inc. (AEHR) SEC Filings & Earnings Calls
EquiReason read 10 Aehr Test Systems, Inc. SEC filings in the last 12 months. Latest: DEF 14A on 2026-09-09 — Proxy statement for 2026 annual meeting; no material event..
Source: SEC EDGAR filings · figures as of 2026-05-29 · read by EquiReason
- Market cap
- 1.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
9 Sep 2026DEF 14AProxy statement for 2026 annual meeting; no material event.open
Figures in the filing · each found in the filing text
| Net Income (Loss) · FY2026 | $-7M | +82% y/y |
Risks flagged
Performance-based compensation not earned
“Based on the Company performance for the year, the Compensation Committee determined that Gayn Erickson, Chris P. Siu, and Alberto Salamone did not earn a revenue-based and profit-based cash bonus for fiscal 2026.” · word for word
27 Jul 202610-KRevenue $50M (-15% y/y); Gross Margin 35.3; Cash and cash equivalents $116M; Guidance: Expectation of return to profitability in FY2027open
Figures in the filing · each found in the filing text
| Revenue · FY2026 | $50M | -15% y/y |
| Gross Margin · FY2026 | 35.3% | |
| Cash and cash equivalents · 2026-05-29 | $117M | |
| Net cash provided by financing activities · FY2026 | $97M |
Guidance
Expectation of return to profitability in FY2027
Company expects return to profitability in FY2027, supported by substantial backlog and visibility into near-term customer demand, but near-term demand remains pressured by EV weakness
Risks flagged
EV Power Semiconductor Demand Weakness
“Revenue decreased by $9.0 million in fiscal year 2026 compared to fiscal year 2025, primarily due to a $19.9 million decrease in wafer-level contactor revenue driven by significantly lower shipments, reflecting continued softness in demand related to electric vehicles.” · word for word
Tariff and Trade Policy Risk
“Gross margin decreased by 5.3 percentage points primarily due to higher assembly and warranty costs, increased freight expenses, and higher tariffs on imported parts following the government policy changes.” · word for word
Customer Concentration and Cyclicality
“A significant portion of our business depends upon the capital expenditures of semiconductor manufacturers. Capital expenditures by these companies depend upon, among other things, the current and anticipated market demand for semiconductors and the products that utilize them.” · word for word
14 Jul 20268-K · 2.02Record quarterly bookings of $60.7M, effective backlog $100.6M, revenue guidance FY27 $130-150M (160-200% YoY growth), driven by AI, silicon photonics, and power semiconductor demand.earningsopen
Figures in the filing · each found in the filing text
| Net revenue · Q4-2026 | $19M | +33% y/y |
| GAAP net income (loss) · Q4-2026 | $1M | -148% y/y |
| Non-GAAP net income (loss) · Q4-2026 | $4M | -1900% y/y |
| Bookings · Q4-2026 | $61M | |
| Backlog · 2026-05-29 | $81M | |
| Effective backlog · 2026-07-14 | $101M | |
| Total cash, cash equivalents and restricted cash · 2026-05-29 | $117M | +214% y/y |
| Net revenue (FY) · FY2026 | $50M | -15% y/y |
| GAAP net loss (FY) · FY2026 | $-7M | +82% y/y |
| Non-GAAP net income (FY) · FY2026 | $900000.00 | -80% y/y |
Guidance
FY27 revenue $130-150M (160-200% YoY growth); non-GAAP net income margin 18-22%
Strong guidance raise with record backlog and accelerating demand from AI, silicon photonics, and power semiconductor customers.
Risks flagged
Customer concentration risk: reliance on a few large AI and silicon photonics customers for significant revenue.
“Our lead AI production customer is significantly ramping capacity... Our lead silicon photonics customer is ramping.” · word for word
Execution risk: scaling production to meet rapid demand growth and guidance.
“Projected fiscal 2027 revenue of $130 million to $150 million, representing 2.6x to 3.0x fiscal 2026 revenue.” · word for word
20 Apr 20268-K · 8.01ATM Gross Proceeds $60Mopen
Figures in the filing · each found in the filing text
| ATM Gross Proceeds · Q2-2026 | $60M |
Risks flagged
Share dilution from ATM equity offering; no specific use of proceeds disclosed.
“fully utilized its previously announced at-the-market equity offering program and completed sales of shares of its common stock having aggregate gross proceeds of approximately $60.0 million.” · word for word
8 Apr 20268-K · 1.01Aehr Test Systems entered an equity distribution agreement to sell up to $60M of common stock at-the-market via William Blair and Craig-Hallum. No obligation to sell; ATM facility provides capital flexibility.open
Risks flagged
Dilution risk from potential full utilization of ATM facility
“Up to $60M in shares may be sold, diluting existing shareholders.”
8 Apr 202610-QRevenue $10M (-44% y/y); Revenue $31M (-31% y/y); Gross Margin 32.7open
Figures in the filing · each found in the filing text
| Revenue · Q3-2026 | $10M | -44% y/y |
| Revenue · 9M-2026 | $31M | -31% y/y |
| Gross Margin · Q3-2026 | 32.7% | |
| Gross Margin · 9M-2026 | 30.9% | |
| Cash, cash equivalents, and restricted cash · 2026-02-27 | $37M | |
| Net cash flows used in operating activities · 9M-2026 | $-5M |
Risks flagged
Sustained losses may require valuation allowance on deferred tax assets
“However, because we incurred pretax losses in fiscal 2025, and losses continued through the nine months ended February 27, 2026, management continues to reassess at each reporting date whether sufficient positive evidence exists to support realization of our U.S. DTAs.” · word for word
Tariff cost pressure on gross margin
“Gross margin decreased by 12.9 percentage points primarily due to ... higher tariffs on imported parts following the government policy changes.” · word for word
7 Apr 20268-K · 2.02, 5.03Net revenue $10M (-44% y/y); GAAP net loss $-3M; Non-GAAP net loss $-2M; Guidance: H2 bookings guidance raised to high end of $60-80M rangeearningsopen
Figures in the filing · each found in the filing text
| Net revenue · Q3-2026 | $10M | -44% y/y |
| GAAP net loss · Q3-2026 | $-3M | |
| Non-GAAP net loss · Q3-2026 | $-2M | |
| Bookings · Q3-2026 | $37M | |
| Backlog · Q3-2026 | $39M | |
| Effective backlog · Q3-2026 | $51M | |
| Total cash, cash equivalents and restricted cash · Q3-2026 | $37M |
Guidance
H2 bookings guidance raised to high end of $60-80M range
Company raised H2 bookings guidance to high end of $60-80M range, indicating strong demand.
Risks flagged
Revenue decline YoY despite strong bookings
“Net revenue declined from $18.3M to $10.3M YoY.”
12 Jan 202610-QRevenue $10M (-27% y/y); Gross Margin 25.7; Operating Cash Flow $-1Mopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $10M | -27% y/y |
| Gross Margin · Q2-2026 | 25.7% | |
| Operating Cash Flow · H1-2026 | $-1M | |
| Balance Cash · Q2-2026 | $31M |
Risks flagged
EV demand softness
“lower shipments of contactors due to the ongoing softness in demand for electric vehicles.” · word for word
Gross margin pressure from tariffs
“higher tariffs on imported parts following recent government policy changes.” · word for word
8 Jan 20268-K · 2.02Net revenue $10M (-27% y/y); GAAP net loss $-3M; Non-GAAP net loss $-1M; Guidance: Bookings expected $60M-$80M in H2 FY2026earningsopen
Figures in the filing · each found in the filing text
| Net revenue · Q2-2026 | $10M | -27% y/y |
| GAAP net loss · Q2-2026 | $-3M | |
| Non-GAAP net loss · Q2-2026 | $-1M | |
| Bookings · Q2-2026 | $6M | |
| Backlog · Q2-2026 | $12M | |
| Effective backlog · Q2-2026 | $18M | |
| Total cash, cash equivalents and restricted cash · Q2-2026 | $31M |
Guidance
Bookings expected $60M-$80M in H2 FY2026
Guidance reinstated with strong bookings forecast for H2 FY2026, driven by AI processor demand.
Risks flagged
Revenue decline and net loss in Q2; reliance on AI processor demand for recovery.
“Revenue down 26.7% YoY; GAAP net loss widened to $(3.2)M.”
Aehr Test Systems, Inc. — questions
- What did Aehr Test Systems, Inc. file recently?
- 10 SEC filings in the last 12 months. Latest: DEF 14A on 2026-09-09 — Proxy statement for 2026 annual meeting; no material event.
Every figure on this page comes from Aehr Test Systems, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.